
Medicare Drug Pricing Negotiations Advance
Deconstructed
Corruption, Medicare, and the Pharmaceutical Industry
This chapter delves into the corrupt history surrounding the Louisiana congressman, Billy Tozan, and how his actions led to Medicare's inability to negotiate with drug companies. It discusses the flaws in the initial drug coverage plan, the influence of the pharmaceutical industry on healthcare policy, and the lack of progress in addressing high drug prices during both the Obama and Trump administrations.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.